Quantcast

Latest Juvenile myelomonocytic leukemia Stories

2014-01-08 12:28:20

NEW YORK, Jan. 8, 2014 /PRNewswire/ -- Bone marrow transplants are a $1.3 billion market and the fastest-growing hospital procedure in the U.S.

2013-12-09 14:08:58

Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem-cell transplants from mismatched and unrelated donors.

2013-12-09 10:45:08

Patients with myelodysplastic syndromes (MDS) who were as old as 74 fared as well with stem cell transplantation as did patients in the 60-to-65 age range.

2013-12-09 10:43:09

Hematopoietic stem cell transplantation (HSCT), once considered an effective yet risky alternative to drug therapy for blood cancer, has become more accessible and successful in a wide range of patients as a result of major advances in transplant strategies and technologies.

2013-12-09 10:11:07

Hematopoietic stem cell transplantation (HSCT), once considered an effective yet risky alternative to drug therapy for blood cancer, has become more accessible and successful in a wide range of patients as a result of major advances in transplant strategies and technologies.

2012-12-11 12:00:01

Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy.

2012-05-19 23:02:42

Gold Rush Cure Foundation expresses praise for Health Canada's decision to approve the stem cell therapy Prochymal for the treatment of Graft-versus-host disease in children. Laguna

2012-05-09 21:35:10

For the first time, scientists at Fred Hutchinson Cancer Research Center have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic side effects of chemotherapy.

2012-04-07 23:00:52

A revolutionary physician-friendly integrated clinical information solution. Omaha, NE (PRWEB) April 07, 2012 OTTR™ Chronic Care Solutions, an Omaha-based

2011-12-13 01:08:02

Patients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likely to have graft failure but less likely to experience graft-versus-host disease, a condition caused by the donor cells attacking the recipient's body, if the transplanted blood cells come directly from a donor's bone marrow, rather than from blood stem cells circulating in the donor's bloodstream (PBSCs).


Word of the Day
zill
  • One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.
The word 'zill' comes from a Turkish word meaning "cymbals".
Related